These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 16233888)
1. 1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose. Timonen M; Kankaanranta L; Lundbom N; Collan J; Kangasmäki A; Kortesniemi M; Häkkinen AM; Lönngren A; Karjalainen S; Rasilainen M; Leinonen J; Huitti T; Jääskeläinen J; Kouri M; Savolainen S; Heikkinen S Eur J Radiol; 2005 Nov; 56(2):154-9. PubMed ID: 16233888 [TBL] [Abstract][Full Text] [Related]
2. Multi-nuclear MRS and 19F MRI of 19F-labelled and 10B-enriched p-boronophenylalanine-fructose complex to optimize boron neutron capture therapy: phantom studies at high magnetic fields. Porcari P; Capuani S; Campanella R; La Bella A; Migneco LM; Maraviglia B Phys Med Biol; 2006 Jun; 51(12):3141-54. PubMed ID: 16757868 [TBL] [Abstract][Full Text] [Related]
3. In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT). Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Campanella R; Migneco LM; Pastore FS; Maraviglia B Phys Med Biol; 2008 Dec; 53(23):6979-89. PubMed ID: 19001698 [TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT; Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940 [TBL] [Abstract][Full Text] [Related]
5. T2 corrected quantification method of L-p-boronophenylalanine using proton magnetic resonance spectroscopy for boron neutron capture therapy. Yamamoto Y; Isobe T; Yamamoto T; Shibata Y; Anno I; Nakai K; Shirakawa M; Matsushita A; Sato E; Matsumura A Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S345-7. PubMed ID: 19406648 [TBL] [Abstract][Full Text] [Related]
6. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy. Zuo CS; Prasad PV; Busse P; Tang L; Zamenhof RG Med Phys; 1999 Jul; 26(7):1230-6. PubMed ID: 10435522 [TBL] [Abstract][Full Text] [Related]
8. Acquisition-weighted MRSI for detection and quantification of BNCT 10B-carrier L-p-boronophenylalanine-fructose complex, a phantom study. Timonen M; Kankaanranta L; Lundbom N; Kortesniemi M; Seppälä T; Kouri M; Savolainen S; Heikkinen S J Radiat Res; 2009 Sep; 50(5):435-40. PubMed ID: 19584572 [TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Mäkitie A; Seppänen M; Minn H; Kotiluoto P; Auterinen I; Savolainen S; Kouri M; Joensuu H Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):475-82. PubMed ID: 17689034 [TBL] [Abstract][Full Text] [Related]
10. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008). H-Stenstam B Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284 [No Abstract] [Full Text] [Related]
15. In vivo 19F MR imaging and spectroscopy for the BNCT optimization. Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Migneco LM; Campanella R; Maraviglia B; Pastore FS Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S365-8. PubMed ID: 19375924 [TBL] [Abstract][Full Text] [Related]
16. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study. Kankaanranta L; Seppälä T; Koivunoro H; Välimäki P; Beule A; Collan J; Kortesniemi M; Uusi-Simola J; Kotiluoto P; Auterinen I; Serèn T; Paetau A; Saarilahti K; Savolainen S; Joensuu H Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):369-76. PubMed ID: 21236605 [TBL] [Abstract][Full Text] [Related]
17. 1H MRS of a boron neutron capture therapy 10B-carrier, L-p-boronophenylalanine-fructose complex, BPA-F: phantom studies at 1.5 and 3.0 T. Heikkinen S; Kangasmäki A; Timonen M; Kankaanranta L; Häkkinen AM; Lundbom N; Vähätalo J; Savolainen S Phys Med Biol; 2003 Apr; 48(8):1027-39. PubMed ID: 12741499 [TBL] [Abstract][Full Text] [Related]
18. Ion microscopy imaging of 10B from p-boronophenylalanine in a brain tumor model for boron neutron capture therapy. Smith DR; Chandra S; Coderre JA; Morrison GH Cancer Res; 1996 Oct; 56(19):4302-6. PubMed ID: 8813111 [TBL] [Abstract][Full Text] [Related]
19. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity. Coderre JA; Chanana AD; Joel DD; Elowitz EH; Micca PL; Nawrocky MM; Chadha M; Gebbers JO; Shady M; Peress NS; Slatkin DN Radiat Res; 1998 Feb; 149(2):163-70. PubMed ID: 9457896 [TBL] [Abstract][Full Text] [Related]